1. Yang, Ming, Wang, Yucheng, He, Liming, Shi, Xinxin, Huang, Shuwei. 2024. Comprehensive bioinformatics analysis reveals the role of cuproptosis-related gene Ube2d3 in myocardial infarction. In Frontiers in immunology, 15, 1353111. doi:10.3389/fimmu.2024.1353111. https://pubmed.ncbi.nlm.nih.gov/38440726/
2. Gao, Xiaojia, Wang, Wenbo, Yang, Hui, Zhou, Fuxiang, Zhou, Yunfeng. . UBE2D3 gene overexpression increases radiosensitivity of EC109 esophageal cancer cells in vitro and in vivo. In Oncotarget, 7, 32543-53. doi:10.18632/oncotarget.8869. https://pubmed.ncbi.nlm.nih.gov/27105523/
3. Liu, Tingting, Wei, Jianshe. 2023. Validation of a Novel Cuproptosis-Related Prognostic Gene Marker and Differential Expression Associated with Lung Adenocarcinoma. In Current issues in molecular biology, 45, 8502-8518. doi:10.3390/cimb45100536. https://pubmed.ncbi.nlm.nih.gov/37886979/
4. Bao, Jing, Sun, Rui, Pan, Zhenjiang, Wei, Shepeng. 2024. UBE2D3 regulated by WTAP-mediated m6A modification inhibits temozolomide chemosensitivity in glioblastoma. In Naunyn-Schmiedeberg's archives of pharmacology, 398, 919-931. doi:10.1007/s00210-024-03327-w. https://pubmed.ncbi.nlm.nih.gov/39085511/
5. Chen, Hongqing, Hu, Qiongying, Wen, Tian, Wang, Lun, Shen, Xiaofei. 2023. Arteannuin B, a sesquiterpene lactone from Artemisia annua, attenuates inflammatory response by inhibiting the ubiquitin-conjugating enzyme UBE2D3-mediated NF-κB activation. In Phytomedicine : international journal of phytotherapy and phytopharmacology, 124, 155263. doi:10.1016/j.phymed.2023.155263. https://pubmed.ncbi.nlm.nih.gov/38181532/
6. Ma, Wanru, Hu, Junhua. 2023. The linear ANRIL transcript P14AS regulates the NF-κB signaling to promote colon cancer progression. In Molecular medicine (Cambridge, Mass.), 29, 162. doi:10.1186/s10020-023-00761-z. https://pubmed.ncbi.nlm.nih.gov/38041015/